1. Home
  2. SRTS vs IZTC Comparison

SRTS vs IZTC Comparison

Compare SRTS & IZTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRTS
  • IZTC
  • Stock Information
  • Founded
  • SRTS 2010
  • IZTC 2019
  • Country
  • SRTS United States
  • IZTC United States
  • Employees
  • SRTS N/A
  • IZTC N/A
  • Industry
  • SRTS Medical/Dental Instruments
  • IZTC Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SRTS Health Care
  • IZTC Health Care
  • Exchange
  • SRTS Nasdaq
  • IZTC Nasdaq
  • Market Cap
  • SRTS 118.2M
  • IZTC 111.5M
  • IPO Year
  • SRTS 2016
  • IZTC 2024
  • Fundamental
  • Price
  • SRTS $6.77
  • IZTC $11.49
  • Analyst Decision
  • SRTS Strong Buy
  • IZTC
  • Analyst Count
  • SRTS 2
  • IZTC 0
  • Target Price
  • SRTS $12.50
  • IZTC N/A
  • AVG Volume (30 Days)
  • SRTS 244.3K
  • IZTC 46.5K
  • Earning Date
  • SRTS 02-06-2025
  • IZTC 02-15-2025
  • Dividend Yield
  • SRTS N/A
  • IZTC N/A
  • EPS Growth
  • SRTS N/A
  • IZTC N/A
  • EPS
  • SRTS 0.57
  • IZTC N/A
  • Revenue
  • SRTS $41,308,000.00
  • IZTC N/A
  • Revenue This Year
  • SRTS $65.04
  • IZTC N/A
  • Revenue Next Year
  • SRTS $24.87
  • IZTC N/A
  • P/E Ratio
  • SRTS $11.51
  • IZTC N/A
  • Revenue Growth
  • SRTS 65.62
  • IZTC 145.01
  • 52 Week Low
  • SRTS $2.61
  • IZTC $8.50
  • 52 Week High
  • SRTS $9.33
  • IZTC $23.00
  • Technical
  • Relative Strength Index (RSI)
  • SRTS 40.52
  • IZTC N/A
  • Support Level
  • SRTS $6.38
  • IZTC N/A
  • Resistance Level
  • SRTS $7.62
  • IZTC N/A
  • Average True Range (ATR)
  • SRTS 0.43
  • IZTC 0.00
  • MACD
  • SRTS -0.05
  • IZTC 0.00
  • Stochastic Oscillator
  • SRTS 29.55
  • IZTC 0.00

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

About IZTC Invizyne Technologies Inc. Common Stock

Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.

Share on Social Networks: